Zhejiang Int'L Group Co Ltd (SHE:000411) — Market Cap & Net Worth
Market Cap & Net Worth: Zhejiang Int'L Group Co Ltd (000411)
Zhejiang Int'L Group Co Ltd (SHE:000411) has a market capitalization of $809.52 Million (CN¥5.53 Billion) as of May 3, 2026. Listed on the SHE stock exchange, this China-based company holds position #10095 globally and #2881 in its home market, demonstrating a -2.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Int'L Group Co Ltd's stock price CN¥10.60 by its total outstanding shares 521894334 (521.89 Million). Analyse Zhejiang Int'L Group Co Ltd operating cash flow efficiency to see how efficiently the company converts income to cash.
Zhejiang Int'L Group Co Ltd Market Cap History: 2015 to 2026
Zhejiang Int'L Group Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.56 Billion to $809.52 Million (-3.85% CAGR).
Zhejiang Int'L Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Int'L Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Zhejiang Int'L Group Co Ltd's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.55x
Zhejiang Int'L Group Co Ltd's market cap is 1.55 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.56 Billion | $15.47 Billion | $68.76 Million | 0.10x | 22.75x |
| 2016 | $1.30 Billion | $17.26 Billion | $86.85 Million | 0.08x | 14.97x |
| 2017 | $1.17 Billion | $18.91 Billion | $83.49 Million | 0.06x | 14.02x |
| 2018 | $743.67 Million | $20.49 Billion | $93.85 Million | 0.04x | 7.92x |
| 2019 | $723.49 Million | $24.60 Billion | $337.67 Million | 0.03x | 2.14x |
| 2020 | $1.16 Billion | $25.01 Billion | $342.81 Million | 0.05x | 3.38x |
| 2021 | $880.16 Million | $26.73 Billion | $396.13 Million | 0.03x | 2.22x |
| 2022 | $849.46 Million | $30.62 Billion | $462.53 Million | 0.03x | 1.84x |
| 2023 | $831.44 Million | $32.05 Billion | $488.73 Million | 0.03x | 1.70x |
| 2024 | $813.34 Million | $33.35 Billion | $525.52 Million | 0.02x | 1.55x |
Competitor Companies of 000411 by Market Capitalization
Companies near Zhejiang Int'L Group Co Ltd in the global market cap rankings as of May 3, 2026.
Key companies related to Zhejiang Int'L Group Co Ltd by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #16 globally with a market cap of $862.20 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #23 globally with a market cap of $547.37 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #37 globally with a market cap of $365.30 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #16 | Eli Lilly and Company | NYSE:LLY | $862.20 Billion | $963.33 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #23 | Johnson & Johnson | NYSE:JNJ | $547.37 Billion | $227.19 |
| #37 | AbbVie Inc | NYSE:ABBV | $365.30 Billion | $206.60 |
Zhejiang Int'L Group Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Zhejiang Int'L Group Co Ltd's market cap moved from $1.56 Billion to $ 809.52 Million, with a yearly change of -3.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥809.52 Million | -16.86% |
| 2025 | CN¥973.71 Million | +19.72% |
| 2024 | CN¥813.34 Million | -2.18% |
| 2023 | CN¥831.44 Million | -2.12% |
| 2022 | CN¥849.46 Million | -3.49% |
| 2021 | CN¥880.16 Million | -24.02% |
| 2020 | CN¥1.16 Billion | +60.11% |
| 2019 | CN¥723.49 Million | -2.71% |
| 2018 | CN¥743.67 Million | -36.48% |
| 2017 | CN¥1.17 Billion | -9.95% |
| 2016 | CN¥1.30 Billion | -16.89% |
| 2015 | CN¥1.56 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Zhejiang Int'L Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $809.52 Million USD |
| MoneyControl | $809.52 Million USD |
| MarketWatch | $809.52 Million USD |
| marketcap.company | $809.52 Million USD |
| Reuters | $809.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Int'L Group Co Ltd
Zhejiang Int'l Group Co.,Ltd. engages in the wholesale and retail of pharmaceuticals and medical devices. It offers chemical drugs, biological products, and Chinese patent medicine. The company was founded in 1950 and is based in Hangzhou, China.